NCT07477457 2026-03-17
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
Memorial Sloan Kettering Cancer Center
American Society of Clinical Oncology
Centre Leon Berard
University Hospital, Strasbourg, France
Oslo University Hospital
Tianjin Medical University Second Hospital
West China Hospital
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Cancer Trials Ireland
Helsinki University Central Hospital
Skane University Hospital
Leiden University Medical Center
Herlev Hospital